APO Research
Talk to an analyst

APO RESEARCH · REPORT

Diagnostic Radiopharmaceuticals

Radiopharmaceuticals refer to a class of special medicines containing radionuclides for medical diagnosis and treatment. Compounds or biological preparations containing radionuclide labels used for medical diagnosis or treatment in the body. Diagnostic radiopharmaceuticals are radioisotopes that bind to biomolecules that can locate specific organs, tissues or cells in the body. These radiopharmaceuticals can be used to diagnose diseases.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Radiopharmaceuticals refer to a class of special medicines containing radionuclides for medical diagnosis and treatment. Compounds or biological preparations containing radionuclide labels used for medical diagnosis or treatment in the body. Diagnostic radiopharmaceuticals are radioisotopes that bind to biomolecules that can locate specific organs, tissues or cells in the body. These radiopharmaceuticals can be used to diagnose diseases.

Selected research

Market Analysis & Forecast

Global Diagnostic Radiopharmaceuticals Market Analysis and Forecast 2026-2032

30 December 2025198 pages

Choose your research edition.

Industry ResearchDiagnostic Radiopharmaceuticals Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Diagnostic Radiopharmaceuticals Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Diagnostic Radiopharmaceuticals Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Diagnostic Radiopharmaceuticals Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Diagnostic Radiopharmaceuticals Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Radiopharmaceuticals refer to a class of special medicines containing radionuclides for medical diagnosis and treatment. Compounds or biological preparations containing radionuclide labels used for medical diagnosis or treatment in the body. Diagnostic radiopharmaceuticals are radioisotopes that bind to biomolecules that can locate specific organs, tissues or cells in the body. These radiopharmaceuticals can be used to diagnose diseases.

North America is the world's major consumer region, with sales accounting for 41.59% of the global total in 2019. Europe is also a major consumer region, accounting for 24.5% of the global market. China is also a very important consumer region due to the large number of cancers. At present, products represented by Cardinal Health, GE Healthcare, Curium Pharma, Jubilant Pharma, Bracco Imaging, etc. occupy a major position in the global market.

This report presents an overview of global market for Diagnostic Radiopharmaceuticals, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

Read the full market overview

This report researches the key producers of Diagnostic Radiopharmaceuticals, also provides the sales of main regions and countries. Of the upcoming market potential for Diagnostic Radiopharmaceuticals, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Diagnostic Radiopharmaceuticals sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Diagnostic Radiopharmaceuticals market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Diagnostic Radiopharmaceuticals sales, projected growth trends, production technology, application and end-user industry.

Diagnostic Radiopharmaceuticals Segment by Company

Cardinal Health

GE Healthcare

Curium Pharma

Jubilant Pharma

Bracco Imaging

Advanced Accelerator Applications

SIEMENS

China Isotope & Radiation

Dongcheng Pharmaceutical Group

Lantheus

Eli Lilly

Diagnostic Radiopharmaceuticals Segment by Type

Technetium 99

Fluorine 18

Other

Diagnostic Radiopharmaceuticals Segment by Application

Oncology

Cardiology

Other

Diagnostic Radiopharmaceuticals Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diagnostic Radiopharmaceuticals market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Diagnostic Radiopharmaceuticals and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diagnostic Radiopharmaceuticals.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Diagnostic Radiopharmaceuticals in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Diagnostic Radiopharmaceuticals manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Diagnostic Radiopharmaceuticals sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Diagnostic Radiopharmaceuticals Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Technetium 99 Major Manufacturers Table 3. Fluorine 18 Major Manufacturers Table 4. Other Major Manufacturers Table 5. Global Diagnostic Radiopharmaceuticals Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Oncology Major Manufacturers Table 7. Cardiology Major Manufacturers Table 8. Other Major Manufacturers Table 9. Diagnostic Radiopharmaceuticals Industry Trends Table 10. Diagnostic Radiopharmaceuticals Industry Drivers Table 11. Diagnostic Radiopharmaceuticals Industry Opportunities and Challenges Table 12. Diagnostic Radiopharmaceuticals Industry Restraints Table 13. Global Diagnostic Radiopharmaceuticals Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Diagnostic Radiopharmaceuticals Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Diagnostic Radiopharmaceuticals Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Region (2021-2026) Table 17. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Region (2027-2032) Table 18. Global Diagnostic Radiopharmaceuticals Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Diagnostic Radiopharmaceuticals Sales by Region (2021-2026) & (K Units) Table 20. Global Diagnostic Radiopharmaceuticals Sales by Region (2027-2032) & (K Units) Table 21. Global Diagnostic Radiopharmaceuticals Sales Market Share by Region (2021-2026) Table 22. Global Diagnostic Radiopharmaceuticals Sales Market Share by Region (2027-2032) Table 23. Global Diagnostic Radiopharmaceuticals Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Diagnostic Radiopharmaceuticals Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Diagnostic Radiopharmaceuticals Sales Market Share by Manufacturers (2021-2026) Table 27. Global Diagnostic Radiopharmaceuticals Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Diagnostic Radiopharmaceuticals Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Diagnostic Radiopharmaceuticals Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Diagnostic Radiopharmaceuticals Manufacturers, Product Type & Application Table 31. Global Diagnostic Radiopharmaceuticals Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Diagnostic Radiopharmaceuticals by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Diagnostic Radiopharmaceuticals Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Diagnostic Radiopharmaceuticals Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Diagnostic Radiopharmaceuticals Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Type (2021-2026) Table 38. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Type (2027-2032) Table 39. Global Diagnostic Radiopharmaceuticals Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Diagnostic Radiopharmaceuticals Sales by Type (2021-2026) & (K Units) Table 41. Global Diagnostic Radiopharmaceuticals Sales by Type (2027-2032) & (K Units) Table 42. Global Diagnostic Radiopharmaceuticals Sales Market Share by Type (2021-2026) Table 43. Global Diagnostic Radiopharmaceuticals Sales Market Share by Type (2027-2032) Table 44. Global Diagnostic Radiopharmaceuticals Price by Type (2021-2026) & (US$/Unit) Table 45. Global Diagnostic Radiopharmaceuticals Price by Type (2027-2032) & (US$/Unit) Table 46. Global Diagnostic Radiopharmaceuticals Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Diagnostic Radiopharmaceuticals Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Diagnostic Radiopharmaceuticals Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Application (2021-2026) Table 50. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Application (2027-2032) Table 51. Global Diagnostic Radiopharmaceuticals Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Diagnostic Radiopharmaceuticals Sales by Application (2021-2026) & (K Units) Table 53. Global Diagnostic Radiopharmaceuticals Sales by Application (2027-2032) & (K Units) Table 54. Global Diagnostic Radiopharmaceuticals Sales Market Share by Application (2021-2026) Table 55. Global Diagnostic Radiopharmaceuticals Sales Market Share by Application (2027-2032) Table 56. Global Diagnostic Radiopharmaceuticals Price by Application (2021-2026) & (US$/Unit) Table 57. Global Diagnostic Radiopharmaceuticals Price by Application (2027-2032) & (US$/Unit) Table 58. Cardinal Health Company Information Table 59. Cardinal Health Business Overview Table 60. Cardinal Health Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Cardinal Health Diagnostic Radiopharmaceuticals Product Portfolio Table 62. Cardinal Health Recent Development Table 63. GE Healthcare Company Information Table 64. GE Healthcare Business Overview Table 65. GE Healthcare Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. GE Healthcare Diagnostic Radiopharmaceuticals Product Portfolio Table 67. GE Healthcare Recent Development Table 68. Curium Pharma Company Information Table 69. Curium Pharma Business Overview Table 70. Curium Pharma Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Curium Pharma Diagnostic Radiopharmaceuticals Product Portfolio Table 72. Curium Pharma Recent Development Table 73. Jubilant Pharma Company Information Table 74. Jubilant Pharma Business Overview Table 75. Jubilant Pharma Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Jubilant Pharma Diagnostic Radiopharmaceuticals Product Portfolio Table 77. Jubilant Pharma Recent Development Table 78. Bracco Imaging Company Information Table 79. Bracco Imaging Business Overview Table 80. Bracco Imaging Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Bracco Imaging Diagnostic Radiopharmaceuticals Product Portfolio Table 82. Bracco Imaging Recent Development Table 83. Advanced Accelerator Applications Company Information Table 84. Advanced Accelerator Applications Business Overview Table 85. Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Product Portfolio Table 87. Advanced Accelerator Applications Recent Development Table 88. SIEMENS Company Information Table 89. SIEMENS Business Overview Table 90. SIEMENS Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. SIEMENS Diagnostic Radiopharmaceuticals Product Portfolio Table 92. SIEMENS Recent Development Table 93. China Isotope & Radiation Company Information Table 94. China Isotope & Radiation Business Overview Table 95. China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. China Isotope & Radiation Diagnostic Radiopharmaceuticals Product Portfolio Table 97. China Isotope & Radiation Recent Development Table 98. Dongcheng Pharmaceutical Group Company Information Table 99. Dongcheng Pharmaceutical Group Business Overview Table 100. Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Product Portfolio Table 102. Dongcheng Pharmaceutical Group Recent Development Table 103. Lantheus Company Information Table 104. Lantheus Business Overview Table 105. Lantheus Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Lantheus Diagnostic Radiopharmaceuticals Product Portfolio Table 107. Lantheus Recent Development Table 108. Eli Lilly Company Information Table 109. Eli Lilly Business Overview Table 110. Eli Lilly Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Eli Lilly Diagnostic Radiopharmaceuticals Product Portfolio Table 112. Eli Lilly Recent Development Table 113. North America Diagnostic Radiopharmaceuticals Revenue by Type (2021-2026) & (US$ Million) Table 114. North America Diagnostic Radiopharmaceuticals Revenue by Type (2027-2032) & (US$ Million) Table 115. North America Diagnostic Radiopharmaceuticals Sales by Type (2021-2026) & (K Units) Table 116. North America Diagnostic Radiopharmaceuticals Sales by Type (2027-2032) & (K Units) Table 117. North America Diagnostic Radiopharmaceuticals Sales Price by Type (2021-2026) & (US$/Unit) Table 118. North America Diagnostic Radiopharmaceuticals Sales Price by Type (2027-2032) & (US$/Unit) Table 119. North America Diagnostic Radiopharmaceuticals Revenue by Application (2021-2026) & (US$ Million) Table 120. North America Diagnostic Radiopharmaceuticals Revenue by Application (2027-2032) & (US$ Million) Table 121. North America Diagnostic Radiopharmaceuticals Sales by Application (2021-2026) & (K Units) Table 122. North America Diagnostic Radiopharmaceuticals Sales by Application (2027-2032) & (K Units) Table 123. North America Diagnostic Radiopharmaceuticals Sales Price by Application (2021-2026) & (US$/Unit) Table 124. North America Diagnostic Radiopharmaceuticals Sales Price by Application (2027-2032) & (US$/Unit) Table 125. North America Diagnostic Radiopharmaceuticals Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. North America Diagnostic Radiopharmaceuticals Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 127. North America Diagnostic Radiopharmaceuticals Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 128. North America Diagnostic Radiopharmaceuticals Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 129. North America Diagnostic Radiopharmaceuticals Sales by Country (2021-2026) & (K Units) Table 130. North America Diagnostic Radiopharmaceuticals Sales by Country (2027-2032) & (K Units) Table 131. North America Diagnostic Radiopharmaceuticals Sales Price by Country (2021-2026) & (US$/Unit) Table 132. North America Diagnostic Radiopharmaceuticals Sales Price by Country (2027-2032) & (US$/Unit) Table 133. United States Diagnostic Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 134. Canada Diagnostic Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 135. Mexico Diagnostic Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 136. Europe Diagnostic Radiopharmaceuticals Revenue by Type (2021-2026) & (US$ Million) Table 137. Europe Diagnostic Radiopharmaceuticals Revenue by Type (2027-2032) & (US$ Million) Table 138. Europe Diagnostic Radiopharmaceuticals Sales by Type (2021-2026) & (K Units) Table 139. Europe Diagnostic Radiopharmaceuticals Sales by Type (2027-2032) & (K Units) Table 140. Europe Diagnostic Radiopharmaceuticals Sales Price by Type (2021-2026) & (US$/Unit) Table 141. Europe Diagnostic Radiopharmaceuticals Sales Price by Type (2027-2032) & (US$/Unit) Table 142. Europe Diagnostic Radiopharmaceuticals Revenue by Application (2021-2026) & (US$ Million) Table 143. Europe Diagnostic Radiopharmaceuticals Revenue by Application (2027-2032) & (US$ Million) Table 144. Europe Diagnostic Radiopharmaceuticals Sales by Application (2021-2026) & (K Units) Table 145. Europe Diagnostic Radiopharmaceuticals Sales by Application (2027-2032) & (K Units) Table 146. Europe Diagnostic Radiopharmaceuticals Sales Price by Application (2021-2026) & (US$/Unit) Table 147. Europe Diagnostic Radiopharmaceuticals Sales Price by Application (2027-2032) & (US$/Unit) Table 148. Europe Diagnostic Radiopharmaceuticals Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 149. Europe Diagnostic Radiopharmaceuticals Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 150. Europe Diagnostic Radiopharmaceuticals Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 151. Europe Diagnostic Radiopharmaceuticals Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 152. Europe Diagnostic Radiopharmaceuticals Sales by Country (2021-2026) & (K Units) Table 153. Europe Diagnostic Radiopharmaceuticals Sales by Country (2027-2032) & (K Units) Table 154. Europe Diagnostic Radiopharmaceuticals Sales Price by Country (2021-2026) & (US$/Unit) Table 155. Europe Diagnostic Radiopharmaceuticals Sales Price by Country (2027-2032) & (US$/Unit) Table 156. Germany Diagnostic Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 157. France Diagnostic Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 158. U.K. Diagnostic Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 159. Italy Diagnostic Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 160. Russia Diagnostic Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 161. Spain Diagnostic Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 162. Netherlands Diagnostic Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 163. Switzerland Diagnostic Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 164. Sweden Diagnostic Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 165. Poland Diagnostic Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 166. China Diagnostic Radiopharmaceuticals Revenue by Type (2021-2026) & (US$ Million) Table 167. China Diagnostic Radiopharmaceuticals Revenue by Type (2027-2032) & (US$ Million) Table 168. China Diagnostic Radiopharmaceuticals Sales by Type (2021-2026) & (K Units) Table 169. China Diagnostic Radiopharmaceuticals Sales by Type (2027-2032) & (K Units) Table 170. China Diagnostic Radiopharmaceuticals Sales Price by Type (2021-2026) & (US$/Unit) Table 171. China Diagnostic Radiopharmaceuticals Sales Price by Type (2027-2032) & (US$/Unit) Table 172. China Diagnostic Radiopharmaceuticals Revenue by Application (2021-2026) & (US$ Million) Table 173. China Diagnostic Radiopharmaceuticals Revenue by Application (2027-2032) & (US$ Million) Table 174. China Diagnostic Radiopharmaceuticals Sales by Application (2021-2026) & (K Units) Table 175. China Diagnostic Radiopharmaceuticals Sales by Application (2027-2032) & (K Units) Table 176. China Diagnostic Radiopharmaceuticals Sales Price by Application (2021-2026) & (US$/Unit) Table 177. China Diagnostic Radiopharmaceuticals Sales Price by Application (2027-2032) & (US$/Unit) Table 178. Asia Diagnostic Radiopharmaceuticals Revenue by Type (2021-2026) & (US$ Million) Table 179. Asia Diagnostic Radiopharmaceuticals Revenue by Type (2027-2032) & (US$ Million) Table 180. Asia Diagnostic Radiopharmaceuticals Sales by Type (2021-2026) & (K Units) Table 181. Asia Diagnostic Radiopharmaceuticals Sales by Type (2027-2032) & (K Units) Table 182. Asia Diagnostic Radiopharmaceuticals Sales Price by Type (2021-2026) & (US$/Unit) Table 183. Asia Diagnostic Radiopharmaceuticals Sales Price by Type (2027-2032) & (US$/Unit) Table 184. Asia Diagnostic Radiopharmaceuticals Revenue by Application (2021-2026) & (US$ Million) Table 185. Asia Diagnostic Radiopharmaceuticals Revenue by Application (2027-2032) & (US$ Million) Table 186. Asia Diagnostic Radiopharmaceuticals Sales by Application (2021-2026) & (K Units) Table 187. Asia Diagnostic Radiopharmaceuticals Sales by Application (2027-2032) & (K Units) Table 188. Asia Diagnostic Radiopharmaceuticals Sales Price by Application (2021-2026) & (US$/Unit) Table 189. Asia Diagnostic Radiopharmaceuticals Sales Price by Application (2027-2032) & (US$/Unit) Table 190. Asia Diagnostic Radiopharmaceuticals Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 191. Asia Diagnostic Radiopharmaceuticals Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 192. Asia Diagnostic Radiopharmaceuticals Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 193. Asia Diagnostic Radiopharmaceuticals Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 194. Asia Diagnostic Radiopharmaceuticals Sales by Country (2021-2026) & (K Units) Table 195. Asia Diagnostic Radiopharmaceuticals Sales by Country (2027-2032) & (K Units) Table 196. Asia Diagnostic Radiopharmaceuticals Sales Price by Country (2021-2026) & (US$/Unit) Table 197. Asia Diagnostic Radiopharmaceuticals Sales Price by Country (2027-2032) & (US$/Unit) Table 198. Japan Diagnostic Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 199. South Korea Diagnostic Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 200. India Diagnostic Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 201. Australia Diagnostic Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 202. Taiwan Diagnostic Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 203. Southeast Asia Diagnostic Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 204. SAMEA Diagnostic Radiopharmaceuticals Revenue by Type (2021-2026) & (US$ Million) Table 205. SAMEA Diagnostic Radiopharmaceuticals Revenue by Type (2027-2032) & (US$ Million) Table 206. SAMEA Diagnostic Radiopharmaceuticals Sales by Type (2021-2026) & (K Units) Table 207. SAMEA Diagnostic Radiopharmaceuticals Sales by Type (2027-2032) & (K Units) Table 208. SAMEA Diagnostic Radiopharmaceuticals Sales Price by Type (2021-2026) & (US$/Unit) Table 209. SAMEA Diagnostic Radiopharmaceuticals Sales Price by Type (2027-2032) & (US$/Unit) Table 210. SAMEA Diagnostic Radiopharmaceuticals Revenue by Application (2021-2026) & (US$ Million) Table 211. SAMEA Diagnostic Radiopharmaceuticals Revenue by Application (2027-2032) & (US$ Million) Table 212. SAMEA Diagnostic Radiopharmaceuticals Sales by Application (2021-2026) & (K Units) Table 213. SAMEA Diagnostic Radiopharmaceuticals Sales by Application (2027-2032) & (K Units) Table 214. SAMEA Diagnostic Radiopharmaceuticals Sales Price by Application (2021-2026) & (US$/Unit) Table 215. SAMEA Diagnostic Radiopharmaceuticals Sales Price by Application (2027-2032) & (US$/Unit) Table 216. SAMEA Diagnostic Radiopharmaceuticals Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 217. SAMEA Diagnostic Radiopharmaceuticals Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 218. SAMEA Diagnostic Radiopharmaceuticals Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 219. SAMEA Diagnostic Radiopharmaceuticals Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 220. SAMEA Diagnostic Radiopharmaceuticals Sales by Country (2021-2026) & (K Units) Table 221. SAMEA Diagnostic Radiopharmaceuticals Sales by Country (2027-2032) & (K Units) Table 222. SAMEA Diagnostic Radiopharmaceuticals Sales Price by Country (2021-2026) & (US$/Unit) Table 223. SAMEA Diagnostic Radiopharmaceuticals Sales Price by Country (2027-2032) & (US$/Unit) Table 224. Brazil Diagnostic Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 225. Argentina Diagnostic Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 226. Chile Diagnostic Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 227. Colombia Diagnostic Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 228. Peru Diagnostic Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 229. Saudi Arabia Diagnostic Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 230. Israel Diagnostic Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 231. UAE Diagnostic Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 232. Turkey Diagnostic Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 233. Iran Diagnostic Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 234. Egypt Diagnostic Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 235. Key Raw Materials Table 236. Raw Materials Key Suppliers Table 237. Diagnostic Radiopharmaceuticals Distributors List Table 238. Diagnostic Radiopharmaceuticals Customers List Table 239. Research Programs/Design for This Report Table 240. Authors List of This Report Table 241. Secondary Sources Table 242. Primary Sources List of Figures Figure 1. Diagnostic Radiopharmaceuticals Image Figure 2. Global Diagnostic Radiopharmaceuticals Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Diagnostic Radiopharmaceuticals Market Size Share 2021 VS 2025 VS 2032 Figure 4. Technetium 99 Image Figure 5. Fluorine 18 Image Figure 6. Other Image Figure 7. Global Diagnostic Radiopharmaceuticals Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Diagnostic Radiopharmaceuticals Market Size Share 2021 VS 2025 VS 2032 Figure 9. Oncology Image Figure 10. Cardiology Image Figure 11. Other Image Figure 12. Global Diagnostic Radiopharmaceuticals Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Diagnostic Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Figure 14. Global Diagnostic Radiopharmaceuticals Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Region (2021-2032) Figure 17. Global Diagnostic Radiopharmaceuticals Sales (2021-2032) & (K Units) Figure 18. Global Diagnostic Radiopharmaceuticals Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Diagnostic Radiopharmaceuticals Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Diagnostic Radiopharmaceuticals Sales YoY (2021-2032) & (K Units) Figure 21. Europe Diagnostic Radiopharmaceuticals Sales YoY (2021-2032) & (K Units) Figure 22. China Diagnostic Radiopharmaceuticals Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Diagnostic Radiopharmaceuticals Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Diagnostic Radiopharmaceuticals Sales YoY (2021-2032) & (K Units) Figure 25. Global Diagnostic Radiopharmaceuticals Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Diagnostic Radiopharmaceuticals Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Diagnostic Radiopharmaceuticals Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Type (2021-2032) Figure 31. Global Diagnostic Radiopharmaceuticals Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Diagnostic Radiopharmaceuticals Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Diagnostic Radiopharmaceuticals Sales Market Share by Type (2021-2032) Figure 34. Global Diagnostic Radiopharmaceuticals Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Application (2021-2032) Figure 37. Global Diagnostic Radiopharmaceuticals Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Diagnostic Radiopharmaceuticals Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Diagnostic Radiopharmaceuticals Sales Market Share by Application (2021-2032) Figure 40. North America Diagnostic Radiopharmaceuticals Revenue Share by Type (2021-2032) Figure 41. North America Diagnostic Radiopharmaceuticals Sales Share by Type (2021-2032) Figure 42. North America Diagnostic Radiopharmaceuticals Revenue Share by Application (2021-2032) Figure 43. North America Diagnostic Radiopharmaceuticals Sales Share by Application (2021-2032) Figure 44. North America Diagnostic Radiopharmaceuticals Revenue Share by Country (2021-2032) Figure 45. North America Diagnostic Radiopharmaceuticals Sales Share by Country (2021-2032) Figure 46. Europe Diagnostic Radiopharmaceuticals Revenue Share by Type (2021-2032) Figure 47. Europe Diagnostic Radiopharmaceuticals Sales Share by Type (2021-2032) Figure 48. Europe Diagnostic Radiopharmaceuticals Revenue Share by Application (2021-2032) Figure 49. Europe Diagnostic Radiopharmaceuticals Sales Share by Application (2021-2032) Figure 50. Europe Diagnostic Radiopharmaceuticals Revenue Share by Country (2021-2032) Figure 51. Europe Diagnostic Radiopharmaceuticals Sales Share by Country (2021-2032) Figure 52. China Diagnostic Radiopharmaceuticals Revenue Share by Type (2021-2032) Figure 53. China Diagnostic Radiopharmaceuticals Sales Share by Type (2021-2032) Figure 54. China Diagnostic Radiopharmaceuticals Revenue Share by Application (2021-2032) Figure 55. China Diagnostic Radiopharmaceuticals Sales Share by Application (2021-2032) Figure 56. Asia Diagnostic Radiopharmaceuticals Revenue Share by Type (2021-2032) Figure 57. Asia Diagnostic Radiopharmaceuticals Sales Share by Type (2021-2032) Figure 58. Asia Diagnostic Radiopharmaceuticals Revenue Share by Application (2021-2032) Figure 59. Asia Diagnostic Radiopharmaceuticals Sales Share by Application (2021-2032) Figure 60. Asia Diagnostic Radiopharmaceuticals Revenue Share by Country (2021-2032) Figure 61. Asia Diagnostic Radiopharmaceuticals Sales Share by Country (2021-2032) Figure 62. SAMEA Diagnostic Radiopharmaceuticals Revenue Share by Type (2021-2032) Figure 63. SAMEA Diagnostic Radiopharmaceuticals Sales Share by Type (2021-2032) Figure 64. SAMEA Diagnostic Radiopharmaceuticals Revenue Share by Application (2021-2032) Figure 65. SAMEA Diagnostic Radiopharmaceuticals Sales Share by Application (2021-2032) Figure 66. SAMEA Diagnostic Radiopharmaceuticals Revenue Share by Country (2021-2032) Figure 67. SAMEA Diagnostic Radiopharmaceuticals Sales Share by Country (2021-2032) Figure 68. Diagnostic Radiopharmaceuticals Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Diagnostic Radiopharmaceuticals Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Technetium 99
  • Fluorine 18
  • Other
Applications
  • Oncology
  • Cardiology
  • Other
Companies covered
  • Cardinal Health
  • GE Healthcare
  • Curium Pharma
  • Jubilant Pharma
  • Bracco Imaging
  • Advanced Accelerator Applications
  • SIEMENS
  • China Isotope & Radiation
  • Dongcheng Pharmaceutical Group
  • Lantheus
  • Eli Lilly

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Diagnostic Radiopharmaceuticals Market by Type
  3. 1.2.1 Global Diagnostic Radiopharmaceuticals Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Technetium 99
  5. 1.2.3 Fluorine 18
  6. 1.2.4 Other
  7. 1.3 Diagnostic Radiopharmaceuticals Market by Application
  8. 1.3.1 Global Diagnostic Radiopharmaceuticals Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Oncology
  10. 1.3.3 Cardiology
  11. 1.3.4 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Diagnostic Radiopharmaceuticals Market Dynamics
  1. 2.1 Diagnostic Radiopharmaceuticals Industry Trends
  2. 2.2 Diagnostic Radiopharmaceuticals Industry Drivers
  3. 2.3 Diagnostic Radiopharmaceuticals Industry Opportunities and Challenges
  4. 2.4 Diagnostic Radiopharmaceuticals Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Diagnostic Radiopharmaceuticals Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Diagnostic Radiopharmaceuticals Revenue by Region
  3. 3.2.1 Global Diagnostic Radiopharmaceuticals Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Diagnostic Radiopharmaceuticals Revenue by Region (2021-2026)
  5. 3.2.3 Global Diagnostic Radiopharmaceuticals Revenue by Region (2027-2032)
  6. 3.2.4 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Diagnostic Radiopharmaceuticals Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Diagnostic Radiopharmaceuticals Sales by Region
  9. 3.4.1 Global Diagnostic Radiopharmaceuticals Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Diagnostic Radiopharmaceuticals Sales by Region (2021-2026)
  11. 3.4.3 Global Diagnostic Radiopharmaceuticals Sales by Region (2027-2032)
  12. 3.4.4 Global Diagnostic Radiopharmaceuticals Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Diagnostic Radiopharmaceuticals Revenue by Manufacturers
  2. 4.1.1 Global Diagnostic Radiopharmaceuticals Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Diagnostic Radiopharmaceuticals Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Diagnostic Radiopharmaceuticals Sales by Manufacturers
  6. 4.2.1 Global Diagnostic Radiopharmaceuticals Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Diagnostic Radiopharmaceuticals Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Diagnostic Radiopharmaceuticals Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Diagnostic Radiopharmaceuticals Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Diagnostic Radiopharmaceuticals Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Diagnostic Radiopharmaceuticals Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Diagnostic Radiopharmaceuticals Manufacturers, Product Type & Application
  13. 4.7 Global Diagnostic Radiopharmaceuticals Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Diagnostic Radiopharmaceuticals Market CR5 and HHI
  16. 4.8.2 2025 Diagnostic Radiopharmaceuticals Tier 1, Tier 2, and Tier 3
5 Diagnostic Radiopharmaceuticals Market by Type
  1. 5.1 Global Diagnostic Radiopharmaceuticals Revenue by Type
  2. 5.1.1 Global Diagnostic Radiopharmaceuticals Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Diagnostic Radiopharmaceuticals Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Diagnostic Radiopharmaceuticals Sales by Type
  6. 5.2.1 Global Diagnostic Radiopharmaceuticals Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Diagnostic Radiopharmaceuticals Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Diagnostic Radiopharmaceuticals Sales Market Share by Type (2021-2032)
  9. 5.3 Global Diagnostic Radiopharmaceuticals Price by Type
6 Diagnostic Radiopharmaceuticals Market by Application
  1. 6.1 Global Diagnostic Radiopharmaceuticals Revenue by Application
  2. 6.1.1 Global Diagnostic Radiopharmaceuticals Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Diagnostic Radiopharmaceuticals Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Diagnostic Radiopharmaceuticals Sales by Application
  6. 6.2.1 Global Diagnostic Radiopharmaceuticals Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Diagnostic Radiopharmaceuticals Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Diagnostic Radiopharmaceuticals Sales Market Share by Application (2021-2032)
  9. 6.3 Global Diagnostic Radiopharmaceuticals Price by Application
7 Company Profiles
  1. 7.1 Cardinal Health
  2. 7.1.1 Cardinal Health Company Information
  3. 7.1.2 Cardinal Health Business Overview
  4. 7.1.3 Cardinal Health Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Cardinal Health Diagnostic Radiopharmaceuticals Product Portfolio
  6. 7.1.5 Cardinal Health Recent Developments
  7. 7.2 GE Healthcare
  8. 7.2.1 GE Healthcare Company Information
  9. 7.2.2 GE Healthcare Business Overview
  10. 7.2.3 GE Healthcare Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 GE Healthcare Diagnostic Radiopharmaceuticals Product Portfolio
  12. 7.2.5 GE Healthcare Recent Developments
  13. 7.3 Curium Pharma
  14. 7.3.1 Curium Pharma Company Information
  15. 7.3.2 Curium Pharma Business Overview
  16. 7.3.3 Curium Pharma Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Curium Pharma Diagnostic Radiopharmaceuticals Product Portfolio
  18. 7.3.5 Curium Pharma Recent Developments
  19. 7.4 Jubilant Pharma
  20. 7.4.1 Jubilant Pharma Company Information
  21. 7.4.2 Jubilant Pharma Business Overview
  22. 7.4.3 Jubilant Pharma Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Jubilant Pharma Diagnostic Radiopharmaceuticals Product Portfolio
  24. 7.4.5 Jubilant Pharma Recent Developments
  25. 7.5 Bracco Imaging
  26. 7.5.1 Bracco Imaging Company Information
  27. 7.5.2 Bracco Imaging Business Overview
  28. 7.5.3 Bracco Imaging Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Bracco Imaging Diagnostic Radiopharmaceuticals Product Portfolio
  30. 7.5.5 Bracco Imaging Recent Developments
  31. 7.6 Advanced Accelerator Applications
  32. 7.6.1 Advanced Accelerator Applications Company Information
  33. 7.6.2 Advanced Accelerator Applications Business Overview
  34. 7.6.3 Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Product Portfolio
  36. 7.6.5 Advanced Accelerator Applications Recent Developments
  37. 7.7 SIEMENS
  38. 7.7.1 SIEMENS Company Information
  39. 7.7.2 SIEMENS Business Overview
  40. 7.7.3 SIEMENS Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 SIEMENS Diagnostic Radiopharmaceuticals Product Portfolio
  42. 7.7.5 SIEMENS Recent Developments
  43. 7.8 China Isotope & Radiation
  44. 7.8.1 China Isotope & Radiation Company Information
  45. 7.8.2 China Isotope & Radiation Business Overview
  46. 7.8.3 China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 China Isotope & Radiation Diagnostic Radiopharmaceuticals Product Portfolio
  48. 7.8.5 China Isotope & Radiation Recent Developments
  49. 7.9 Dongcheng Pharmaceutical Group
  50. 7.9.1 Dongcheng Pharmaceutical Group Company Information
  51. 7.9.2 Dongcheng Pharmaceutical Group Business Overview
  52. 7.9.3 Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Product Portfolio
  54. 7.9.5 Dongcheng Pharmaceutical Group Recent Developments
  55. 7.10 Lantheus
  56. 7.10.1 Lantheus Company Information
  57. 7.10.2 Lantheus Business Overview
  58. 7.10.3 Lantheus Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Lantheus Diagnostic Radiopharmaceuticals Product Portfolio
  60. 7.10.5 Lantheus Recent Developments
  61. 7.11 Eli Lilly
  62. 7.11.1 Eli Lilly Company Information
  63. 7.11.2 Eli Lilly Business Overview
  64. 7.11.3 Eli Lilly Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Eli Lilly Diagnostic Radiopharmaceuticals Product Portfolio
  66. 7.11.5 Eli Lilly Recent Developments
8 North America
  1. 8.1 North America Diagnostic Radiopharmaceuticals Market Size by Type
  2. 8.1.1 North America Diagnostic Radiopharmaceuticals Revenue by Type (2021-2032)
  3. 8.1.2 North America Diagnostic Radiopharmaceuticals Sales by Type (2021-2032)
  4. 8.1.3 North America Diagnostic Radiopharmaceuticals Price by Type (2021-2032)
  5. 8.2 North America Diagnostic Radiopharmaceuticals Market Size by Application
  6. 8.2.1 North America Diagnostic Radiopharmaceuticals Revenue by Application (2021-2032)
  7. 8.2.2 North America Diagnostic Radiopharmaceuticals Sales by Application (2021-2032)
  8. 8.2.3 North America Diagnostic Radiopharmaceuticals Price by Application (2021-2032)
  9. 8.3 North America Diagnostic Radiopharmaceuticals Market Size by Country
  10. 8.3.1 North America Diagnostic Radiopharmaceuticals Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Diagnostic Radiopharmaceuticals Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Diagnostic Radiopharmaceuticals Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Diagnostic Radiopharmaceuticals Market Size by Type
  2. 9.1.1 Europe Diagnostic Radiopharmaceuticals Revenue by Type (2021-2032)
  3. 9.1.2 Europe Diagnostic Radiopharmaceuticals Sales by Type (2021-2032)
  4. 9.1.3 Europe Diagnostic Radiopharmaceuticals Price by Type (2021-2032)
  5. 9.2 Europe Diagnostic Radiopharmaceuticals Market Size by Application
  6. 9.2.1 Europe Diagnostic Radiopharmaceuticals Revenue by Application (2021-2032)
  7. 9.2.2 Europe Diagnostic Radiopharmaceuticals Sales by Application (2021-2032)
  8. 9.2.3 Europe Diagnostic Radiopharmaceuticals Price by Application (2021-2032)
  9. 9.3 Europe Diagnostic Radiopharmaceuticals Market Size by Country
  10. 9.3.1 Europe Diagnostic Radiopharmaceuticals Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Diagnostic Radiopharmaceuticals Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Diagnostic Radiopharmaceuticals Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Diagnostic Radiopharmaceuticals Market Size by Type
  2. 10.1.1 China Diagnostic Radiopharmaceuticals Revenue by Type (2021-2032)
  3. 10.1.2 China Diagnostic Radiopharmaceuticals Sales by Type (2021-2032)
  4. 10.1.3 China Diagnostic Radiopharmaceuticals Price by Type (2021-2032)
  5. 10.2 China Diagnostic Radiopharmaceuticals Market Size by Application
  6. 10.2.1 China Diagnostic Radiopharmaceuticals Revenue by Application (2021-2032)
  7. 10.2.2 China Diagnostic Radiopharmaceuticals Sales by Application (2021-2032)
  8. 10.2.3 China Diagnostic Radiopharmaceuticals Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Diagnostic Radiopharmaceuticals Market Size by Type
  2. 11.1.1 Asia Diagnostic Radiopharmaceuticals Revenue by Type (2021-2032)
  3. 11.1.2 Asia Diagnostic Radiopharmaceuticals Sales by Type (2021-2032)
  4. 11.1.3 Asia Diagnostic Radiopharmaceuticals Price by Type (2021-2032)
  5. 11.2 Asia Diagnostic Radiopharmaceuticals Market Size by Application
  6. 11.2.1 Asia Diagnostic Radiopharmaceuticals Revenue by Application (2021-2032)
  7. 11.2.2 Asia Diagnostic Radiopharmaceuticals Sales by Application (2021-2032)
  8. 11.2.3 Asia Diagnostic Radiopharmaceuticals Price by Application (2021-2032)
  9. 11.3 Asia Diagnostic Radiopharmaceuticals Market Size by Country
  10. 11.3.1 Asia Diagnostic Radiopharmaceuticals Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Diagnostic Radiopharmaceuticals Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Diagnostic Radiopharmaceuticals Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Diagnostic Radiopharmaceuticals Market Size by Type
  2. 12.1.1 SAMEA Diagnostic Radiopharmaceuticals Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Diagnostic Radiopharmaceuticals Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Diagnostic Radiopharmaceuticals Price by Type (2021-2032)
  5. 12.2 SAMEA Diagnostic Radiopharmaceuticals Market Size by Application
  6. 12.2.1 SAMEA Diagnostic Radiopharmaceuticals Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Diagnostic Radiopharmaceuticals Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Diagnostic Radiopharmaceuticals Price by Application (2021-2032)
  9. 12.3 SAMEA Diagnostic Radiopharmaceuticals Market Size by Country
  10. 12.3.1 SAMEA Diagnostic Radiopharmaceuticals Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Diagnostic Radiopharmaceuticals Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Diagnostic Radiopharmaceuticals Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Diagnostic Radiopharmaceuticals Value Chain Analysis
  2. 13.1.1 Diagnostic Radiopharmaceuticals Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Diagnostic Radiopharmaceuticals Production Mode & Process
  6. 13.2 Diagnostic Radiopharmaceuticals Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Diagnostic Radiopharmaceuticals Distributors
  9. 13.2.3 Diagnostic Radiopharmaceuticals Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst